| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.345 | 8.111 | 8.681 | 8.372 | 8.646 | 8.840 | 7.478 | 10.193 | 7.151 |
| Total Income - EUR | - | 4.345 | 8.111 | 8.681 | 8.372 | 8.646 | 8.840 | 7.478 | 10.193 | 7.151 |
| Total Expenses - EUR | - | 697 | 2.695 | 1.516 | 1.645 | 1.569 | 2.158 | 2.394 | 4.068 | 3.543 |
| Gross Profit/Loss - EUR | - | 3.648 | 5.416 | 7.165 | 6.728 | 7.077 | 6.681 | 5.084 | 6.125 | 3.608 |
| Net Profit/Loss - EUR | - | 3.517 | 5.173 | 6.905 | 6.476 | 6.838 | 6.448 | 4.966 | 5.231 | 3.035 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Viliginschi Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 136 | 95 | 56 | 19 | 842 | 719 | 896 | 533 | 405 |
| Current Assets | - | 3.504 | 5.228 | 9.440 | 11.339 | 12.683 | 13.878 | 5.602 | 6.448 | 5.571 |
| Inventories | - | 6 | 33 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 579 | 392 | 668 | 82 | 144 | 992 | 633 | 3.193 | 3.042 |
| Cash | - | 2.920 | 4.803 | 8.767 | 11.257 | 12.538 | 12.887 | 4.969 | 3.254 | 2.529 |
| Shareholders Funds | - | 3.562 | 5.226 | 9.403 | 11.261 | 13.382 | 14.499 | 6.250 | 6.913 | 5.970 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 78 | 121 | 103 | 111 | 170 | 98 | 294 | 185 | 49 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Viliginschi Med Srl